Potentiators of insulin secretion
US7863301B2 · kind B2 · utility
0Cited by
7References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 2004 |
| Grant date | Jan 4, 2011 |
| Priority date | — |
| Expiry date | Jul 23, 2025 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/62
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a recognition that an analog of αKG can increase glucose-induced insulin secretion in vitro and in vivo in animals, particularly in mammals, and more particularly in humans and in rodents. By employing the methods of the invention, insulin secretion can be increased.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.